Discrepancy in insulin regulation between gestational diabetes mellitus (GDM) platelets and placenta

被引:0
|
作者
Li Y. [1 ]
Cooper A. [1 ]
Odibo I.N. [2 ]
Ahmed A. [1 ]
Murphy P. [2 ]
Koonce R. [1 ]
Dajani N.K. [2 ]
Lowery C.L. [2 ]
Roberts D.J. [3 ]
Maroteaux L. [4 ]
Kilic F. [1 ]
机构
[1] Department of Biochemistry and Molecular Biology, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, 72205, AR
[2] Department of Obstetrics and Gynecology, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, 72205, AR
[3] Department of Pathology, Massachusetts General Hospital, Boston, 02114, MA
[4] UMR-S839 INSERM, Université Pierre etMarie Curie, Institutdu Fer a'Moulin, Paris
来源
J. Biol. Chem. | / 18卷 / 9657-9665期
基金
美国国家卫生研究院;
关键词
Tissue - Amino acids - Cell membranes - Histology - Phosphorylation - Platelets - Cytology;
D O I
10.1074/jbc.M116.713693
中图分类号
学科分类号
摘要
Earlier findings have identified the requirement of insulin signaling on maturation and the translocation of serotonin (5-HT) transporter, SERT to the plasma membrane of the trophoblast in placenta. Because of the defect on insulin receptor (IR) in the trophoblast of the gestational diabetes mellitus (GDM)-associated placenta, SERT is found entrapped in the cytoplasm of the GDM-trophoblast. SERT is encoded by the same gene expressed in trophoblast and platelets. Additionally, alteration in plasma 5-HT levels and the 5-HT uptake rates are associated with the aggregation rates of platelets. Therefore, here, we investigated a novel hypothesis that GDM-associated defects in platelet IR should change their 5-HT uptake rates, and this should be a leading factor for thrombosis in GDM maternal blood. The maternal blood and the placentas were obtained at the time of cesarean section from the GDM and non-diabetic subjects (n = 6 for each group), and the platelets and trophoblasts were isolated to determine the IR activity, surface level of SERT, and their 5-HT uptake rates. Interestingly, no significant differences were evident in IR tyrosine phosphorylation or the downstream elements, AKT and S6K in platelets and their aggregation rates in both groups. Furthermore, insulin stimulation up-regulated 5-HT uptake rates of GDM-platelets as it does in the control group. However, the phosphorylation of IR and the downstream elements were significantly lower in GDM-trophoblast and showed no response to the insulin stimulation while they showed 4-fold increase to insulin stimulation in control group. Similarly, the 5-HT uptake rates of GDM-trophoblast and the SERT expression on their surface were severalfold lower compared with control subjects. IR is expressed in all tissues, but it is not known if diabetes affects IR in all tissues equally. Here, for the first time, our findings with clinical samples show that in GDM-associated defect on IR is tissue type-dependent. While IR is impaired in GDM-placenta, it is unaffected in GDM-platelet. © 2016 by The American Society for Biochemistry and Molecular Biology, Inc.
引用
收藏
页码:9657 / 9665
页数:8
相关论文
共 50 条
  • [21] Treatment staisfaction with insulin therapy contributes to glucose control in gestational diabetes mellitus (GDM)
    Ilic, S
    Jovanovic, L
    Mezic, J
    Pettitt, D
    Ohanessian, J
    Bastyr, EJ
    DIABETES, 1999, 48 : A53 - A53
  • [22] C-reactive protein (CRP) and insulin resistance in gestational diabetes mellitus (GDM)
    Liu, Y.
    Du, J.
    Zhao, D.
    Song, X.
    Zhou, L.
    Wang, P.
    Xu, Z.
    DIABETOLOGIA, 2006, 49 : 566 - 567
  • [23] Increased prevalence of VNTR III of the insulin gene in women with gestational diabetes mellitus (GDM)
    Litou, Hariklia
    Anastasiou, Eleni
    Thalassinou, Louminitsa
    Sarika, Helen-Leda
    Philippou, George
    Alevizaki, Maria
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2007, 76 (02) : 223 - 228
  • [24] Gut Dysbiosis at the Time of Diagnosis with Gestational Diabetes Mellitus (GDM) Is an Indicator of Insulin Therapy
    Huang, Lingling
    Thonusin, Chanisa
    Sililas, Palin
    Luewan, Suchaya
    Tongsong, Theera
    Chattipakorn, Nipon
    Chattipakorn, Siriporn C.
    DIABETES, 2021, 70
  • [25] A study on serum Leptin levels and models of Insulin resistance in Gestational Diabetes Mellitus (GDM)
    Rai, T.
    Adiga, U.
    Kamath, Deepika M.
    JOURNAL OF LIVESTOCK SCIENCE, 2023, 14 (04): : 251 - 257
  • [26] The human placenta in gestational diabetes mellitus
    Desoye, Gernot
    Mouzon, Sylvie Hauguel-De
    DIABETES CARE, 2007, 30 : S120 - S126
  • [27] Predictors of Metformin Failure in Gestational Diabetes Mellitus (GDM)
    Khin, May Oo
    Gates, Simon
    Saravanan, Ponnusamy
    DIABETES, 2014, 63 : A339 - A339
  • [28] Gestational diabetes mellitus (GDM), diagnosis, therapy and aftercare
    Schaefer-Graf, Ute
    Laubner, Katharina
    Hummel, Sandra
    Gembruch, Ulrich
    Groten, Tanja
    Kainer, Franz
    Grieshop, Melita
    Bancher-Todesca, Dagmar
    Cervar-Zivakovic, Mila
    Hoesli, Irene
    Kaltheuner, Matthias
    Gellner, Reinhold
    Kautzky-Willer, Alexandra
    Buehrer, Christoph
    DIABETOLOGIE UND STOFFWECHSEL, 2022, 17 : S215 - S225
  • [29] Effect of gestational diabetes mellitus (GDM) on arterial stiffness
    Inci, S.
    Nar, G.
    Balkan, F.
    Aksan, G.
    Degirmenci, H.
    Hamur, H.
    Demirelli, S.
    Dogan, A.
    EUROPEAN HEART JOURNAL, 2014, 35 : 402 - 402
  • [30] The early bioinflammatory milieu in gestational diabetes mellitus (GDM)
    Chavan, Niraj
    Ashford, Kristin
    Wiggins, Amanda
    McCubbin, Andrea
    Barnett, Janine
    O'Brien, John M.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2016, 214 (01) : S96 - S96